Pathogenesis of B-cell superantigen-induced immune complex-mediated inflammation

Infection and Immunity

Volumn 74, Issue 2, 2006, Pages 1196-1203

  Anderson, Amy L ^a   Sporici, Romeo ^a,b   Lambris, John ^a   LaRosa, David ^a   Levinson, Arnold I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; B LYMPHOCYTE SUPERANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MACROPHAGE INFLAMMATORY PROTEIN 2; STAPHYLOCOCCUS PROTEIN A; SUPERANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTHUS PHENOMENON; ARTICLE; B LYMPHOCYTE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE COMPLEX DISEASE; IN VIVO STUDY; INFLAMMATION; MAST CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ARTHUS REACTION; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; NEUTROPHILS; PERITONEAL CAVITY; STAPHYLOCOCCAL PROTEIN A; SUPERANTIGENS;

EID: 31844453716     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.2.1196-1203.2006     Document Type: Article

References (42)

1. Ainsworth, S. K., P. A. Pilla, S. H. Pepkowitz, and P. O'Brien. 1988. Toxicity following protein A treatment of metastatic breast adenocarcinoma. Cancer 61:1495-1500.
2. Arbiser, J. L., J. S. Dzieczkowski, J. V. Harmon, and L. M. Duncan. 1995. Leukocytoclastic vasculitis following staphylococcal protein A column immunoadsorption therapy: two cases and a review of the literature. Arch. Dermatol. 131:707-709.
3. Arthus, M. 1903. Injections répetéés de sérum de cheval chez le lapin. C. R. Soc. Biol. 55:817-820.
4. Baumann, U. N., B. Couchakova, B. Gewecke, J. Kohi, M. C. Carroll, R. E. Schmidt, and J. E. Gessner. 2001. Distinct tissue site-specific requirements of mast cells and complement components C3/5a receptor in IgG immune complex-induced injury of skin and lung. J. Immunol. 167:1022-1027.
5. H3 gene products: natural ligands for HTV gp120. Science 261:1588-1591.
6. Björck, L. 1988. Protein L: a novel bacterial cell wall protein with affinity for Ig L chains. J. Immunol. 140:1194-1197.
7. H4 expressing B cells from apoptosis. J. Immunol. 156:3608-3620.
8. Fearon, D. T, and W. W. Wong. 1983. Complement ligand-receptor interactions that mediate biological responses. Annu. Rev. Immunol. 1:243-271.
9. Gallo, M. L., E. V. Jakobovits, and G. C. Davis. 2000. The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans. Eur. J. Immunol. 30:534-540.
10. Genovese, A., J. P. Bouvet, G. Florio, B. Lamparter-Schummert, L. Bjorck, and G. Marone. 2000. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect. Immun. 68:5517-5524.
11. Godau, J., T. Heller, H. Hawlisch, M. Trappe, E. Howells, J. Best, J. Zwirner, S. Verbeek, P. M. Hogarth, C. Gerard, N. van Rooijen, A. Klos, J. Gessner, and J. Kohn. 2004. C5a initiates the inflammatory cascade in immune complex peritonitis. J. Immunol. 173:3437-3445.
12. Goodyear, C. S., M. Narita, and G. J. Silverman. 2004. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin. J. Immunol. 1:2870-2877.
13. Goodyear, C. S., and G. J. Silverman. 2004. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc. Natl. Acad. Sci. USA 10:11392-11397.
14. Guthrie, T. H., Jr., and A. Oral. 1989. Immune thrombocytopenia purpura: a pilot study of Staphylococcal protein A immunomodulation in refractory patients. Semin. Hematol. 26:3-9.
15. Heller, T., J. E. Gessner, R. E. Schmidt, A. Klos, W. Bautsch, and J. Kohl. 1999. Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis. J. Immunol. 162:5657-5661.
16. Jones, F. R., J. P. Balint, Jr., and H. W. Snyder, Jr. 1986. Selective extracorporeal removal of immunoglobulin G and circulating immune complexes: a review. Plasma Ther. Transfus. Technol. 7:333-349.
17. Kohl, J., and J. E. Gessner. 1999. On the role of complement and Fcγ receptors in the Arthus reaction. Mol. Immunol. 36:893-903.
18. H binding site. J. Immunol. 160:5246-5252.
19. Kozlowski, L. M., G. Silverman, J. D. Lambris, and A. I. Levinson. 1996. Complement activation by a B cell superantigen. J. Immunol. 157:1200-1206.
20. Levinson, A. I., L. Kozlowski, Y. Zheng, and L. M. Wheatley. 1995. B cell superantigens: definition and potential impact on the immune response. J. Clin. Immunol. 15:26S-36S.
21. Levinson, A. L, and L. Kozlowski. 1996. Staphylococcal protein A: functional properties of a model B-cell superantigen, p. 99-106. In M. Zouali (ed.), Human B-cell superantigens. Landes Bioscience Publishers, Austin, Tex.
22. Marone, G., M. Tamburini, M. G. Giudizi, R. Biagiotti, F. Almerigogna, and S. Romagnani. 1987. Mechanism of activation of human basophils by Staphylococcus aureus Cowan I. Infect. Immun. 55:803-809.
23. Mastellos, D., J. C. Papadimitriou, S. Franchini, P. A. Tsonis, and J. D. Lambris. 2001. A novel role of complement: mice deficient in the fifth component of complement exhibit impaired liver regeneration. J. Immunol. 166:2479-2486.
24. Messerschmidt, G. L., D. H. Henry, H. W. Snyder, Jr., J. Bertram, A. Mittelman, S. Ainsworth, J. Fiore, M. V. Viola, J. Louie, E. Ambinder, F. R. MacKintosh, D. J. Higby, P. O'Brien, D. Kiprov, M. Hamberger, Jr., J. P. Balint, L. D. Fisher, W. Perkins, C. M. Pinsky, and F. R. Jones. 1989. Protein A immunotherapy in the treatment of cancer: an update. Semin. Hematol. 26:19-24.
25. Mittelman, A., J. Bertram, D. H. Henry, H. W. Sn.yder, Jr., G. L. Messerschmidt, D. Ciavarella, S. Ainsworth, D. Kiprov, and Z. Arlin. 1989. Treatment of patients with HlV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption. Semin. Hematol. 26:15-18.
26. v mice. J. Exp. Med. 162:1025-1043.
27. Patella, V, J.-P. Bouvet, and G. Marone. 1993. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J. Immunol. 151:5685-5698.
28. Patella, V., V. Casolaro, L. Björck, and G. Marone. 1990. Protein L: a bacterial Ig-binding protein that activates human basophils and mast cells. J. Immunol. 145:3054-3061.
29. H3 region of IgE. J. Immunol. 164:589-595.
30. Qureshi, R., and B. A. Jakschik. 1988. The role of mast cells in thioglycollate-induced inflammation. J. Immunol. 141:2090-2096.
31. Ramos, B. F., R. Qureshi, K. M. Olsen, and B. A. Jakschik. 1990. The importance of mast cells for the neutrophil influx in immune complex-induced peritonitis in mice. J. Immunol. 145:1868-1873.
32. Ramos, B. F., Y. Zhang, R. Qureshi, and B. A. Jakschik. 1991. Mast cells are critical for the production of leukotrienes responsible for neutrophil recruitment in immune complex-induced peritonitis in mice. J. Immunol. 147:1636-1641.
33. Ravetch, J. V. 2002. A full complement of receptors in immune complex diseases. J. Clin. Investig. 110:1759-1761.
34. Razin, E., R. L. Stevens, F. Akiyama, K. Schmid, and K. F. Austen. 1982. Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate. J. Biol. Chem. 257:7229-7236.
35. HIII H chains. J. Immunol. 142:2778-2783.
36. HIII subgroup. J. Immunol. 147:1877-1883.
37. H families S107 and J606 bind to protein A. J. Immunol. 145:2989-2993.
38. Silverman, G. J. 1997. B cell superantigens. Immunol. Today 18:379-386.
39. Silverman, G. J., P. Roben, J.-P. Bouvet, and M. Sasano. 1995. Superantigen properties of a human sialoprotein involved in gut-associated immunity. J. Clin. Investig. 96:417-426.
40. Strey, C. W., M. Markiewski, D. Mastellos, R. Tudoran, L. Greenbaum, and J. D. Lambris. 2003. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198:913-923.
41. Viau, M., N. S. Longo, P. E. Lipsky, L. Bjorck, and M. Zouali. 2004. Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L. Infect. Immun. 72:3515-3523.
42. Zhang, Y., B. F. Ramos, and B. A. Jakschik. 1992. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 258:1957-1959.